1. Home
  2. USLM vs TARS Comparison

USLM vs TARS Comparison

Compare USLM & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

HOLD

Current Price

$127.31

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$81.81

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USLM
TARS
Founded
1948
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
USLM
TARS
Price
$127.31
$81.81
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$76.56
AVG Volume (30 Days)
64.5K
419.7K
Earning Date
02-02-2026
11-04-2025
Dividend Yield
0.18%
N/A
EPS Growth
32.23
N/A
EPS
4.55
N/A
Revenue
$364,849,000.00
$366,100,000.00
Revenue This Year
$22.64
$147.24
Revenue Next Year
$8.38
$53.11
P/E Ratio
$28.75
N/A
Revenue Growth
20.27
182.44
52 Week Low
$80.47
$38.51
52 Week High
$151.16
$85.25

Technical Indicators

Market Signals
Indicator
USLM
TARS
Relative Strength Index (RSI) 51.80 61.85
Support Level $120.24 $78.10
Resistance Level $131.47 $83.34
Average True Range (ATR) 3.92 3.12
MACD 1.08 -0.34
Stochastic Oscillator 43.42 52.75

Price Performance

Historical Comparison
USLM
TARS

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: